Beyond Air (XAIR) Net Equity Issued and Repurchased (2017 - 2026)
Beyond Air (XAIR) reported Net Equity Issued and Repurchased of $3.8 million for Q1 2026, down 79.19% on a YoY basis from $18.3 million in Q1 2025, and up 442.86% sequentially from $700000.0 in Q4 2025.
Beyond Air (XAIR) Net Equity Issued and Repurchased (2017 - 2026) Analysis & Trends
Beyond Air (XAIR) has 9 years of Net Equity Issued and Repurchased data on file, last reported at $3.8 million in Q1 2026.
- For the quarter ending Q1 2026, Net Equity Issued and Repurchased fell 79.19% year-over-year to $3.8 million; the trailing twelve-month figure through Mar 2026 stood at $4.5 million (down 65.87% YoY), and the FY2026 full-year result was $4.5 million, down 76.14% from the prior year.
- Net Equity Issued and Repurchased improved to $3.8 million in Q1 2026, from $700000.0 in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $18.3 million in Q1 2025 to a low of -$18.3 million in Q4 2024.
- A 5-year average of $2.4 million and a median of $3.5 million in 2023 frame the typical range for Net Equity Issued and Repurchased.
- Across the five-year window, Net Equity Issued and Repurchased tumbled 2715.42% in 2023 and jumped 278.17% in 2024, its largest moves.
- Tracing XAIR's Net Equity Issued and Repurchased over 5 years: stood at $214000.0 in 2022, then plunged by 2715.42% to -$5.6 million in 2023, then plunged by 226.21% to -$18.3 million in 2024, then surged by 103.83% to $700000.0 in 2025, then jumped by 442.86% to $3.8 million in 2026.
- Business Quant data shows XAIR's Net Equity Issued and Repurchased at $3.8 million in Q1 2026, $700000.0 in Q4 2025, and $18.3 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 97.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 12.70 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Beyond Air | 2.25 Mn | -10.02 Mn | 94,000.00 | 3.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.80 Mn |
| Mar 31, 2026 | 3.80 Mn |
| Dec 31, 2025 | 700,000.00 |
| Dec 31, 2025 | 700,000.00 |
| Mar 31, 2025 | 18.26 Mn |
| Mar 31, 2025 | 18.26 Mn |
| Dec 31, 2024 | -18.26 Mn |
| Dec 31, 2024 | -18.26 Mn |
| Mar 31, 2024 | 13.18 Mn |
| Mar 31, 2024 | 13.18 Mn |
| Sep 30, 2023 | -5.60 Mn |
| Sep 30, 2023 | -5.60 Mn |
| Jun 30, 2023 | 5.81 Mn |
| Jun 30, 2023 | 5.81 Mn |
| Mar 31, 2023 | 3.49 Mn |
| Mar 31, 2023 | 3.49 Mn |
| Sep 30, 2022 | 214,000.00 |
| Sep 30, 2022 | 214,000.00 |
| Dec 31, 2021 | 10.10 Mn |
| Dec 31, 2021 | 10.10 Mn |